LOXL3 and neoplasm: Accordingly, primary tumors developed in the flanks of syngeneic mice showed a delayed growth upon inoculation of Loxl3-silenced B16-F10 cells compared to those derived from control cells, accompanied by a reduction in tumor incidence and an increase in tumor latency (Figure 6C).